Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3658095010 | Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3658096011 | Acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3676201011 | Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Codeine phosphate | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 30 | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Caffeine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 15 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Is a | Product containing caffeine and codeine and paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Caffeine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Codeine phosphate | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Is a | Product containing only caffeine and codeine and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Codeine phosphate | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Codeine phosphate | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely caffeine 15 milligram and codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet | Plays role | Antitussive therapeutic role | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets